Development of Sulfamoylated 4-(1-Phenyl-1 H-1,2,3-triazol-4-yl)phenol Derivatives as Potent Steroid Sulfatase Inhibitors for Efficient Treatment of Breast Cancer

Artykuł naukowy w czasopiśmie recenzowany

Czasopismo: JOURNAL OF MEDICINAL CHEMISTRY (ISSN: 0022-2623)
Rok wydania: 2022
Strony od-do: 5044 - 5056

---

Cytowanie w formacie Bibtex:
@article{1,
author = "Maciej Masłyk",
title = "Development of Sulfamoylated 4-(1-Phenyl-1 H-1,2,3-triazol-4-yl)phenol Derivatives as Potent Steroid Sulfatase Inhibitors for Efficient Treatment of Breast Cancer",
journal = "JOURNAL OF MEDICINAL CHEMISTRY",
year = "2022",
pages = "5044 - 5056"
}

Cytowanie w formacie APA:
Masłyk, M. (2022). Development of Sulfamoylated 4-(1-Phenyl-1 H-1,2,3-triazol-4-yl)phenol Derivatives as Potent Steroid Sulfatase Inhibitors for Efficient Treatment of Breast Cancer. JOURNAL OF MEDICINAL CHEMISTRY, 5044 - 5056.